MGAM and prostate carcinoma: Antognelli et al. demonstrated that the accumulation of MG-H1 in prostate cancer cells can downregulate the expression of PD-L1, leading to PD-L1-mediated suppression of cytotoxic CD8+ T cells and promoting immune escape of the tumor [85].